Welcome to the Miller Lab at the Medical College of Wisconsin Cancer Center. Our lab is focused on understanding the causes of drug resistance in breast cancer and the discovery of new treatment strategies.
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Meisam Bagheri, Gadisti Aisha Mohamed, Mohammed Ashick Mohamed Saleem, Nevena B Ognjenovic, Hanxu Lu, Fred W Kolling, Owen M Wilkins, Subhadeep Das, Ian S LaCroix, Shivashankar H Nagaraj, Kristen E Muller, Scott A Gerber, Todd W Miller, Diwakar R Pattabiraman.
Cell Rep Med. 2024 Apr 16;5(4):101504. doi: 10.1016/j.xcrm.2024.101504. Epub 2024 Apr 8.
TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha.
Bianca A Romo, Barbara Karakyriakou, Lauren Cressey, Brooke L Brauer, Huijuan Yang, Alexa Warren, Anneka L Johnson, Arminja N Kettenbach, Todd W Miller.
Cancers (Basel). 2024 Feb 20;16(5):845. doi: 10.3390/cancers16050845.
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, Todd W Miller, Diwakar R Pattabiraman, Brock C Christensen.
Epigenomics. 2024 Mar;16(5):293-308. doi: 10.2217/epi-2023-0339. Epub 2024 Feb 15.